Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Rena
资讯
2024-04-07
SHANGHAI,China,April07,2024(GLOBENEWSWIRE)--ShanghaiJunshiBiosciencesCo.,Ltd(“JunshiBiosciences”,HKEX:1877;SSE:688180),aleadinginnovation-drivenbiopharmaceuticalcompanydedi...